Evidence map›Paper›PMID 27273718›Full record

ArticleInvestigative ophthalmology & visual science2016

Hydrogen Sulfide Contributes to Retinal Neovascularization in Ischemia-Induced Retinopathy.

David Gersztenkorn, Ciro Coletta, Shuang Zhu, Yonju Ha, Hua Liu, Hongyan Tie, Jia Zhou, Csaba Szabo, Wenbo Zhang, Massoud Motamedi

Open access · goldAbstract read
In one paragraph

Article in Investigative ophthalmology & visual science, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.2field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Vascular biology of hydrogen sulfide.American journal of physiology. Cell physiology · 2017
    Review
  14. Article
  15. Role of Hydrogen Sulfide in Retinal Diseases.Frontiers in pharmacology · 2017
    Review
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

David GersztenkornCenter for Biomedical Engineering, The University of Texas Medical Branch, Galveston, Texas, United States 2Department of Ophthalmology and Visual Sciences, The University of Texas Medical Branch, Galveston, Texas, United States 3Neuroscience & Cell Biolo.
Ciro ColettaAnesthesiology, The University of Texas Medical Branch, Galveston, Texas, United States.
Shuang ZhuDepartment of Ophthalmology and Visual Sciences, The University of Texas Medical Branch, Galveston, Texas, United States.
Yonju HaDepartment of Ophthalmology and Visual Sciences, The University of Texas Medical Branch, Galveston, Texas, United States.
Hua LiuCenter for Biomedical Engineering, The University of Texas Medical Branch, Galveston, Texas, United States.
Hongyan TieDepartment of Ophthalmology and Visual Sciences, The University of Texas Medical Branch, Galveston, Texas, United States.
Jia ZhouPharmacology and Toxicology, The University of Texas Medical Branch, Galveston, Texas, United States.
Csaba SzaboAnesthesiology, The University of Texas Medical Branch, Galveston, Texas, United States.
Wenbo ZhangDepartment of Ophthalmology and Visual Sciences, The University of Texas Medical Branch, Galveston, Texas, United States 3Neuroscience & Cell Biology, The University of Texas Medical Branch, Galveston, Texas, United States.
Massoud MotamediCenter for Biomedical Engineering, The University of Texas Medical Branch, Galveston, Texas, United States 2Department of Ophthalmology and Visual Sciences, The University of Texas Medical Branch, Galveston, Texas, United States.
The University of Texas Medical Branch at Galveston · US

Funding

Mechanisms of Retinal Neuronal InjuryR01EY022694 · NEI · UNIVERSITY OF TEXAS MED BR GALVESTON · PI ZHANG, WENBO · 2012 to 2021
$3.8M
Regulation of cellular bioenergetics by hydrogen sulfideR01GM107846 · NIGMS · UNIVERSITY OF TEXAS MED BR GALVESTON · PI SZABO, CSABA · 2014 to 2017
$1.2M
NEI NIH HHS R01 EY022694NIGMS NIH HHS R01 GM107846
6 · The paper itself

Abstract

purposeHydrogen sulfide (H2S) is an endogenous gaseous signaling molecule with significant pathophysiological importance, but its role in retinal neovascular diseases is unknown. Hydrogen sulfide is generated from L-cysteine by cystathionine-β-synthase (CBS), cystathionine-γ-lyase (CSE), and/or 3-mercaptopyruvate sulfurtransferase (3-MST). The aim of this study was to investigate the role of H2S in retinal neovascularization (NV) in ischemia-induced retinopathy.

methodsStudies were performed in a murine model of oxygen-induced retinopathy (OIR). Hydrogen sulfide was detected with a fluorescent assay. Western blots and immunohistochemistry were used to assess the changes of H2S-producing enzymes. Gene deletion and pharmacologic inhibition were used to investigate the role of H2S in retinal NV.

resultsHydrogen sulfide production was markedly increased in retinas from OIR mice compared with those from room air (RA) controls. Cystathionine-β-synthase and CSE were significantly increased in OIR retinas, whereas 3-MST was not changed. Cystathionine-β-synthase was expressed throughout the neuronal retina and upregulated in neurons and glia during OIR. Cystathionine-γ-lyase was also localized to multiple retinal layers. Its immunoreactivity was prominently increased in neovascular tufts in OIR. Pharmacologic inhibition of CBS/CSE or genetic deletion of CSE significantly reduced retinal NV in OIR.

conclusionsOur data indicate that the H2S-generating enzymes/H2S contributes to retinal NV in ischemia-induced retinopathy and suggest that blocking this pathway may provide novel therapeutic approaches for the treatment of proliferative retinopathy.

Indexed as

AnimalsBlotting, WesternCystathionine beta-SynthaseCystathionine gamma-LyaseDisease Models, AnimalHydrogen SulfideImmunohistochemistryIschemiaMiceNeovascularization, PathologicNeural PathwaysRetinal NeovascularizationSulfurtransferases3-mercaptopyruvate sulphurtransferaseCystathionine beta-SynthaseCystathionine gamma-LyaseHydrogen SulfideSulfurtransferases

Identifiers

PMID27273718
PMCPMC4904802
OpenAlexW2414579282

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.